Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IPRAGLIFLOZIN L-PROLINE vs IRINOTECAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IPRAGLIFLOZIN L-PROLINE vs IRINOTECAN: Safety Overview

Metric	IPRAGLIFLOZIN L-PROLINE	IRINOTECAN
Total FAERS Reports	124	27,965
Deaths Reported	9	4,530
Death Rate	7.3%	16.2%
Hospitalizations	74	10,384
Average Patient Age	62.1 yrs	58.7 yrs
% Female Patients	37.6%	41.4%
FDA Approval Date	N/A	Apr 11, 2022
Manufacturer	N/A	Armas Pharmaceuticals Inc.
Route	N/A	INTRAVENOUS
Marketing Status	N/A	Prescription